Cite
HARVARD Citation
Ellingson, B. et al. (2018). Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro-oncology. 20 (11), pp. 1525-1535. [Online].